The changing face of direct-to-consumer print advertising: Policy and content issues

Pharmaceutical Medicine

Volumn 24, Issue 3, 2010, Pages 166-177

  MacIas, Wendy ^a   Stavchansky Lewis, Liza ^b   Baek, Tae Hyun ^c  

^a TEXAS CHRISTIAN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

advertising; drug information; legislation; marketing; patient education; pharmaceutical industry.

Indexed keywords

ARIPIPRAZOLE; ATORVASTATIN; DULOXETINE; ETHINYLESTRADIOL PLUS NORELGESTROMIN; FLUTICASONE PROPIONATE PLUS SALMETEROL; PRESCRIPTION DRUG;

ARTICLE; CONTENT ANALYSIS; DIRECT TO CONSUMER ADVERTISING; DRUG INDICATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; JOB SATISFACTION; MEDICAL INFORMATION; POLICY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RELIABILITY; RISK BENEFIT ANALYSIS; SELF REGULATION MODEL; UNITED STATES;

EID: 77954781036     PISSN: 11782595     EISSN: 11791993     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Review of Ophthalmology. Study finds benefit in consumer drug advertising. 2003; 10: 7 [online]. Available from URL: http://www.revophth.com/ index. asp?page=1-310.htm [Accessed 2010 Jun 14]
2. Edwards J. Drugs (prescription). Brandweek 2009; 50 (17): 9
3. Mintel Report. The pharmaceuticals consumer-US-January 2010: the advertising landscape [online]. Available from URL: http://academic.mintel.com/ sinatra/oxygen/display/id=482435 [Accessed 2010 Jun 14]
4. DTC Perspectives. DTC INSIGHTS alert: 'reported' DTC ad spending rebounds in July-Sept. period. 2009Dec 7 [online]. Available from URL: http:// www.dtcperspectives.com/article/DTC-INSIGHTS-Alert+dots+-+em+Reported +em+-DTC-Ad-Spending-Rebounds-in-July∼Sept.-Period/207.html [Accessed 2010 Jan 10]
5. Arnold M. DTC spend down 3%in '07 [editorial]. Medical Marketing &Media 2008 Jun; 43 (6): 28
6. Pettypiece S. Less sex, rock-n-roll as drug makers react toFDA TV ad scrutiny. 2010 Jan 27 [online]. Available from URL: http://www.bloomberg.com/ apps/ news?pid=20601204&sid=aVe6AAgRw-0Y# [Accessed 2010 Feb 18]
7. Reining in direct-to-customer advertising [editorial]. Lancet 2005; 365: 1204
8. DTC in brief [editorial]. DTC Perspectives 2007; 6 (4): 10
9. Edwards J. FDA: quality of DTC ads is in noticeable decline [editorial]. Brandweek 2005; 46 (18): 12
10. US Food and Drug Administration. Warning letters 2009 [online]. Available from URL: www.fda.gov/cder/warn/ [Accessed 2010 Jun 14]
11. Hensley S. J&J gives straight talk on drug risks in new ads [editorial]. Wall Street Journal-Eastern Edition 2005; a: B1
12. Woloshin S, Schwartz LM, Tremmel J, et al. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold? Lancet 2001; 358: 1141-1146
13. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising, 1989-1998: a content analysis of conditions, targets, inducements, and appeals. J Fam Pract 2000; 49 (4): 329-335
14. Bell RA, Wilkes MS, Kravitz RL. The educational value of consumer-targeted prescription drug print advertising. J Fam Pract 2000; 49: 1092-1098
15. Menon AM, Deshpande AP, Perri III M, et al. Consumers' attention to the brief summary in print direct-to-consumer advertisements: perceived usefulness in patient-physicians discussions. J Publ Pol Market 2003; 22 (2): 181-191
16. Parker BJ, Delene LM. Direct-to-consumer prescription drug advertising: content analysis and public policy implications. J Pharmaceut Market Manag 1998; 12 (4): 27-42
17. Parker BJ, Delene LM. The marketing of direct-to-consumer prescription drugs: an examination of advertising content. J PromotManag 1999; 5 (1): 37-55
18. Roth MS. Patterns in direct-to-consumer prescription drug print advertising and their public policy. J Publ Pol Market 1996; 15: 63-75
19. Wilkes MS, Bell RA, Kravitz R. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff 2000; 19: 110-128
20. Mintzes B. An assessment of the health system impacts of direct-to-consumer advertising of prescription medications, volume II: literature review. 2001 [online]. Available from URL: http://www.chspr.ubc.ca// hpru/pdf/dtca-v2- litreview.pdf [Accessed 2002 Dec 10]
21. Calfee JE. Public policy issues in direct-to-consumer advertising of prescription drugs. J Publ Pol Market 2002; 21: 174-193
22. Joseph M, Spake DF, Finney Z. Consumer attitudes toward pharmaceutical direct-to-consumer advertising: an empirical study and the role of income. Int J Pharmaceut Health Market 2008; 2 (2): 117-133
23. USGAO. Prescription drugs: little is known about the effects of direct-toconsumer advertising. Report to the chairman, subcommittee on oversight and investigations, committee on energy and commerce, House of Representatives. Washington, DC: US General Accounting Office, 1991
24. Lexchin J, Mintzes B. Direct-to-consumer advertising of prescription drugs: the evidence says no. J Publ Pol Market 2002; 21: 194-201
25. Paul DP, Handlin A, Stanton ADA. Primary care physicians' attitudes toward direct-to-consumer advertising of prescription drugs: still crazy after all these years. J Consum Market 2002; 19: 564-574
26. Kravitz RL. Direct-to-consumer advertising of prescription drugs: implications for the patient-physician relationship [research study]. J Am Med Assoc 2000; 284: 2244
27. New FDA chief is good news [editorial]. MM&M 2002a Nov: 16-17
28. Teinowitz I. DTC regulation byFDAdebated [editorial]. Advertising Age 2001 July 30; 6
29. Macias W, Lewis LS.Acontent analysis of direct-to-consumer (DTC) prescription drug web sites. J Advertis 2003; 32: 43-56
30. US Food and Drug Administration. Guidance for industry consumerdirected broadcast advertisements [online]. Available from URL: http:// www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm070065.pdf [Accessed 2010 Jun 28]
31. Guidance for Industry. Brief summary: disclosing risk information in consumer- directed print advertisements - draft guidance [online]. Available from URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/ucm069984.pdf [Accessed 2010 Jun 28]
32. Baukus R. DTC advertising [letter]. J Health Communicat 2004; 9: 563
33. Wogalter MS, Smith-Jackson TL, Mills BJ, et al. The effects of print format in direct-to-consumer prescription drug advertisements on risk knowledge and preference. Drug Informat J 2002; 36: 693-705
34. Huh J, Cude BJ. Is the information "fair and balanced" in direct-to-consumer prescription drug websites? J Health Communicat 2004; 9: 529-541
35. Abel GA, Lee SJ, Weeks JC. Direct-to-consumer advertising in oncology: a content analysis of print media. J Clin Oncol 2007; 25 (10): 1267-1271
36. Kopp SW, Bang HK. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications. Health Mark Q 2000; 17 (3): 39-56
37. Macias W, Pashupati K, Stavchansky Lewis L. A wonderful life or diarrheoa and dry mouth: content of direct-to-consumer (DTC) drug advertising on television. Health Commun 2007; 22 (3): 241-252
38. Tversky A, Kahneman D. Judgement under uncertainty: heuristics and biases. Science 1974; 185: 1124-1131
39. Stewart DW, Furse DH. Effective television advertising: a study of 1000 commercials. Lexington (MA): Lexington Books, 1986
40. Macias W, McMillan SJ. The return of the house call: the role of Internet-based interactivity in bringing health information home to older adults. Health Commun 2008; 23 (1): 34-44